TV.QIAGENBIOINFORMATICS.COM
QIAGEN OmicSoft and Biomedical Knowledge Base
Probing OncoLand using OmicSoft Studio
There's more than one way to probe our OncoLand data. With the OmicSoft Studio...
QIAGEN OmicSoft and Biomedical Knowledge Base
Checkpoint inhibitor and immuno-oncology investigation through OmicSoft Lands...
While there is great interest in the scientific community to investigate drug targets...
QIAGEN IPA
IPA deeper dive: Making most out of user’s core/expression analysis
An Ingenuity Pathway Analysis (IPA) deeper dive into the core analysis (also known as...
QIAGEN OmicSoft and Biomedical Knowledge Base
Assessing drug safety with QIAGEN Biomedical KB-AI
Are you a healthcare professional, clinical researcher or data scientist interested in...
QIAGEN CLC Genomics
Antimicrobial resistance (AMR) and multi-locus sequence typing (MLST) with...
You asked, and we’re here to deliver. In this training, we’ll cover how antimicrobial...
Tutorials
OmicSoft API : Flexible API access for complex multi-omics queries
API access to QIAGEN OmicSoft data, you’ll be empowered to get right to the data...
QIAGEN CLC Genomics
De novo assembly, BLAST and genome finishing with QIAGEN CLC Genomics Workbench
This webinar will introduce users to the tools available for short reads (Illumina) as...
QCI Interpret for Oncology
Benefits of integrating targeted next-generation sequencing (NGS) panels into...
Variant detection of multiple genes from a single tumor sample requires high-throughput...
QIAGEN OmicSoft and Biomedical Knowledge Base
Discoveries from comparing user data with high-quality public genomics data
Discoveries from comparing user data with high-quality public genomics data...
QCI Interpret for Oncology
Sample to Insight Oncology
Sample to insight solution for any oncology applocation
QIAGEN IPA
Investigate biomarkers, drug targets and more with QIAGEN IPA BioProfiler
QIAGEN IPA's BioProfiler feature allows you to explore and filter the details behind...
QIAGEN IPA
QIAGEN Ingenuity Pathway Analysis (IPA) summer camp Part 3
• Compare different experimental conditions (different ‘omics data, treatments, time...